Vunthera

Vunthera

Pre-clinical
Utrecht, NetherlandsFounded 2020vunthera.com

Cytomegalovirus is a highly prevalent herpesvirus, with 40 to 80% of the adults having encountered a primary CMV infection in their life, depending on the geographical location. Like other herpesviruses, CMV establishes a harmless but life-long latent infection, hiding with low frequency in monocytes and hematopoietic stem cells. Occasionally, a fraction of these latently infected cells gets reactivated. In healthy individuals, such secondary infections are rapidly dealt with by the immune sy...

Founded
2020
Focus
AntibodiesBiologics

About

Cytomegalovirus is a highly prevalent herpesvirus, with 40 to 80% of the adults having encountered a primary CMV infection in their life, depending on the geographical location. Like other herpesviruses, CMV establishes a harmless but life-long latent infection, hiding with low frequency in monocytes and hematopoietic stem cells. Occasionally, a fraction of these latently infected cells gets reactivated. In healthy individuals, such secondary infections are rapidly dealt with by the immune sy...

Company Info

TypePrivate
Founded2020
LocationUtrecht, Netherlands
StagePre-clinical
SIMILAR COMPANIES
2-BBB Medicines
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile